Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells
Open Access
- 2 November 2016
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 44 (6) , 1234-1247
Abstract
To examine if hypoxia inducible factor-1α (HIF-1α) can induce the upregulation of the purinergic receptor P2Y2 (P2Y2) and thereby promote the viability of human hepatocellular carcinoma (HCC) cells under hypoxic conditions. Archival HCC tumour specimens and corresponding non-cancerous tissues were examined immunohistochemically for P2Y2 protein. A series of in vitro experiments were undertaken using HCC cell lines to determine the effect of hypoxia on HIF-1α and P2Y2 levels, the effect of HIF-1α upregulation on P2Y2 levels, and the effect of P2Y2 upregulation on cell viability under hypoxic conditions. Human HCC specimens were positive for P2Y2. Hypoxia and upregulated HIF-1α both upregulated the P2Y2 levels in HCC cell lines. P2Y2 upregulation using plasmid transfection resulted in enhanced cell viability under hypoxia. Treatment of HepG2 cells with the selective P2Y2 antagonist MRS2312 downregulated P2Y2 and reduced cell viability in five HCC cell lines. P2Y2 knockdown reduced HepG2 cell viability under hypoxia. These present results suggest that HCC cells upregulate P2Y2 levels during hypoxia, which in turn promotes their growth. P2Y2 could be a potential therapeutic target for treating HCC.Keywords
This publication has 49 references indexed in Scilit:
- Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future DirectionsAsian Pacific Journal of Cancer Prevention, 2016
- Trends and Patterns of Hepatocellular Carcinoma Treatment in KoreaJournal of Korean Medical Science, 2016
- Nucleotides Acting at P2Y Receptors: Connecting Structure and FunctionMolecular Pharmacology, 2015
- An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenibKorean Journal of Hepato-Biliary-Pancreatic Surgery, 2015
- Purinergic signalling: from discovery to current developmentsExperimental Physiology, 2014
- Loss of P2Y2 Nucleotide Receptors Enhances Early Pathology in the TgCRND8 Mouse Model of Alzheimer's DiseaseMolecular Neurobiology, 2013
- Purinergic Signalling: Pathophysiology and Therapeutic PotentialThe Keio Journal of Medicine, 2013
- Purinergic P2Y2 Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver InjuryGastroenterology, 2012
- Purines, Purinergic Receptors, and CancerCancer Research, 2012
- International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyPharmacological Reviews, 2006